Brief: India Globalization Says Clinical Trial On Alzheimer’s Patients Indicates Positive Safety And Tolerability Data

IGC Pharma

14/12/2021 14:30

Dec 14 (Reuters) - India Globalization Capital Inc  IGC.A :
    * CLINICAL TRIAL ON ALZHEIMER’S PATIENTS INDICATES POSITIVE
SAFETY
AND TOLERABILITY DATA FOR IGC’S THC-BASED INVESTIGATIONAL NEW
DRUG

Source text for Eikon:  ID:nBw4q7v1za 
Further company coverage:  IGC.A 

 ((Reuters.Briefs@thomsonreuters.com;))